EXCITING PRESS

A Multi-Bagger Stock In The Making: InMode Has All The Right Traits

A Multi-Bagger Stock In The Making: InMode Has All The Right Traits

“InMode is the best stock in the quickly growing medical aesthetic devices industry,” proclaims Stock Bros Research, adding, “this is why it has vastly outperformed its peers.” InMode (Nasdaq: INMD) is an asset-light business with high returns on capital and a flawless balance sheet with no debt. Industry demand for its technology devices remains high, seeing record revenues in Q3 2020 with a 49% YoY increase.

InMode has many qualities of a multi-bagger stock, surpassing the competition in operational efficiency and brand recognition. In addition, the company insiders have shown that they believe in the company as no shares traded hands throughout the pandemic. As a result, InMode will continue to see strong growth.

Read the article here.

InMode is pleased to be part of the China – Israel Innovation Hub

InMode is pleased to be part of the China – Israel Innovation Hub

InMode is pleased to be part of the China – Israel Innovation Hub, inaugurated by an event showcasing the latest innovative health and beauty products, and fostering collaboration on medical technology between the Israeli and Chinese industries. InMode presented its latest platforms, technologies that remodel skin and tissue on the face and body. The Evolve and Evoke platforms have demonstrated success by providing physicians with an intelligent hands-free method of performing aesthetic treatments.

See the video here https://www.linkedin.com/feed/update/urn:li:activity:67425563319342776

Analysts Just Published A Bright New Outlook For InMode

Analysts Just Published A Bright New Outlook For InMode

Shareholders in InMode (NASDAQ: INMD) will be thrilled to learn that analysts have delivered a major upgrade to their near-term forecasts. The consensus statutory numbers for both revenue and earnings per share (EPS) increased, with a much more bullish outlook on the company’s business prospects. After the upgrade, analysts are predicting revenues of $183M in 2020, reflecting a 15% improvement over the last 12 months.

Read the article here.

Shark Bites: InMode Gets Back to Rally Mode

Shark Bites: InMode Gets Back to Rally Mode

James DePorre, a Real Money contributor, author and CEO of Shark Investing, writes that InMode (NASDAQ: INMD) is growing rapidly and had strong quarter-over-quarter growth with steady improvement in the stock. InMode announced that it anticipates record revenues in the third quarter of 2020 of $59.2M to $59.5M, versus analyst expectations of just $38.2M. Earnings are expected to be in the range of $0.60 to $0.62 per share versus analyst expectations of $0.46. The company’s 2020 revenue estimate jumps to around $192M from estimates of $160M and should produce a substantial jump in EPS. These numbers substantially surpass market estimates. With numbers this strong, I anticipate that INMD to be the success that I believed it would be back in January.

Read the article here.

If You Had Bought InMode Stock A Year Ago, You Could Pocket A 61% Gain Today

If You Had Bought InMode Stock A Year Ago, You Could Pocket A 61% Gain Today

The InMode (NASDAQ:INMD) share price is up 61% in the last year, clearly besting the market return of around 20%. Share price momentum remains respectable, with a gain of 51% in the last three months. This suggests the company is continuing to win over new investors. If it can keep that out-performance up over the long term, investors will do very well!

Read the article here.

How can we help?

Please select a topic below related to your inquiry.

Find a clinic
Questions about treatments
Questions about our technologies or workstations
General inquiries email or call 1.855.411.2639

GET STARTED

Which technology is right for you?

Contact Us
Contact Us

Contact Us